![]() |
市場調査レポート
商品コード
1691777
同種骨移植市場- 世界の産業規模、シェア、動向、機会、予測、用途別、タイプ別、エンドユーザー別、地域別セグメント、競合、2020年~2030年Bone Allografts Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Type, By End-user, By Region & Competition, 2020-2030F |
||||||
カスタマイズ可能
|
同種骨移植市場- 世界の産業規模、シェア、動向、機会、予測、用途別、タイプ別、エンドユーザー別、地域別セグメント、競合、2020年~2030年 |
出版日: 2025年03月24日
発行: TechSci Research
ページ情報: 英文 182 Pages
納期: 2~3営業日
|
同種骨移植の世界市場規模は2024年に14億5,000万米ドルとなり、予測期間では2030年までCAGR 7.25%で目覚ましい成長が予測されています。
同種骨移植の世界市場は、高齢化人口の増加、整形外科疾患の増加、医療技術の進歩などを背景に、近年大きな成長を遂げています。同種骨移植は、ドナーからレシピエントへの骨組織の移植を伴うもので、整形外科手術や歯科手術の重要な一部となっています。同種骨移植は、ヒトドナーからの組織移植片であり、様々な整形外科的および歯科的用途に使用されます。主に、骨欠損、骨折、脊椎固定、関節再建、歯科治療などの手術に使用されます。同種骨移植は、自家骨移植(患者自身の体から採取した骨組織)に代わる実行可能な選択肢として機能し、骨の治癒を促進し、痛みや回復時間を短縮する能力により人気を博しています。2024年の記事によると、英国では75歳から84歳の推定63%が筋骨格系の疾患と共存しており、これは全年齢層の中で最も高い有病率です。全体として、筋骨格系疾患の有病率は年齢とともに上昇する傾向にあり、高齢者人口に大きな影響を与えることが強調されています。
市場概要 | |
---|---|
予測期間 | 2026-2030 |
市場規模:2024年 | 14億5,000万米ドル |
市場規模:2030年 | 21億9,000万米ドル |
CAGR:2025年~2030年 | 7.25% |
急成長セグメント | 脱灰骨基質 |
最大市場 | 北米 |
変形性関節症、骨折、脊椎変形などの整形外科疾患の世界の有病率は増加傾向にあります。この動向は同種骨移植の需要に拍車をかけています。同種骨移植は、これらの疾患に対処するための外科的介入において極めて重要だからです。低侵襲手術やロボット支援手術など、手術手技の技術的進歩が同種骨移植の採用を増加させています。これらの技術は、骨移植術の精度と有効性を高めています。高齢化社会は、骨粗鬆症や退行性関節疾患など、加齢に伴う骨の問題を抱えやすいです。高齢者人口は増加の一途をたどっており、同種骨移植の需要は大幅に増加すると予想されます。組織移植を規制する厳格な枠組みにより、同種骨移植の安全性と品質が向上しています。これが消費者の信頼と市場の成長を後押ししています。同種骨移植の利点に関する患者および医療専門家の意識の高まりが、外科手術における同種骨移植移植片の受け入れと利用を高めています。
筋骨格系障害の発生率の増加が同種骨移植の世界市場を牽引
サプライチェーンの制約
技術の進歩
The Global Bone Allografts Market was valued at USD 1.45 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.25% through 2030. The global bone allografts market has witnessed substantial growth in recent years, driven by an increasing aging population, rising cases of orthopedic disorders, and advancements in medical technology. Bone allografts, which involve the transplantation of bone tissue from a donor to a recipient, have become a crucial part of orthopedic and dental procedures. Bone allografts are tissue grafts sourced from a human donor and are used for various orthopedic and dental applications. They are primarily employed in surgeries to treat bone defects, fractures, spinal fusion, joint reconstruction, and dental procedures. Bone allografts serve as a viable alternative to autografts (bone tissue from the patient's own body) and have gained popularity due to their ability to promote bone healing and reduce pain and recovery time. According to a 2024 article, an estimated 63% of individuals aged 75 to 84 in the United Kingdom were living with a musculoskeletal condition, the highest prevalence among all age groups. Overall, the prevalence of musculoskeletal conditions tends to rise with age, highlighting the significant impact on the elderly population.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 1.45 Billion |
Market Size 2030 | USD 2.19 Billion |
CAGR 2025-2030 | 7.25% |
Fastest Growing Segment | Demineralized Bone Matrices |
Largest Market | North America |
The global prevalence of orthopedic disorders, including osteoarthritis, fractures, and spinal deformities, is on the rise. This trend has fueled the demand for bone allografts, as they are crucial in surgical interventions to address these conditions. Technological advancements in surgical techniques, such as minimally invasive surgeries and robotic-assisted procedures, have increased the adoption of bone allografts. These techniques enhance the precision and efficacy of bone grafting procedures. The aging population is prone to age-related bone issues, such as osteoporosis and degenerative joint diseases. As the elderly population continues to grow, the demand for bone allografts is expected to rise significantly. Stringent regulatory frameworks governing tissue transplantation have improved the safety and quality of bone allografts. This has bolstered consumer confidence and market growth. Increased awareness among both patients and healthcare professionals about the benefits of bone allografts has led to higher acceptance and utilization of these grafts in surgical procedures.
Key Market Drivers
Rising Incidence of Musculoskeletal Disorders is Driving the Global Bone Allografts Market
Musculoskeletal disorders have become a significant global health concern, affecting millions of people across the world. These disorders encompass a wide range of conditions that impact the muscles, bones, tendons, ligaments, and other parts of the musculoskeletal system. Conditions like osteoarthritis, osteoporosis, fractures, and spinal disorders have been on the rise due to various factors such as aging populations and sedentary lifestyles. To address the growing demand for musculoskeletal treatments, the global bone allografts market is experiencing remarkable growth.
Musculoskeletal disorders represent a wide spectrum of health issues, and their prevalence is increasing at an alarming rate globally. As the world's population ages, the incidence of musculoskeletal disorders, particularly osteoarthritis and osteoporosis, is rising. Aging leads to a natural loss of bone density and muscle mass, making individuals more susceptible to fractures and joint degeneration. Modern lifestyles often involve extended periods of sitting, limited physical activity, and poor posture. These factors can contribute to muscle imbalances and musculoskeletal problems, including back pain and repetitive strain injuries. Obesity is a significant risk factor for musculoskeletal disorders. Excess weight places additional stress on joints, leading to conditions like osteoarthritis and lower back pain. Jobs that involve repetitive motions, heavy lifting, or prolonged periods of standing can lead to musculoskeletal injuries. Workers in industries like construction, healthcare, and manufacturing are at a higher risk. Participation in sports and physical activities carries a risk of injury, including fractures and ligament tears, which can contribute to the overall burden of musculoskeletal disorders.
Key Market Challenges
Supply Chain Constraints
One of the primary challenges facing the bone allografts market is the consistent and reliable supply of graft materials. The availability of suitable donor tissues can be affected by factors such as changes in regulations, limitations on donor pool size, and disruptions in the supply chain due to natural disasters or health crises like the COVID-19 pandemic. Ensuring a stable supply chain is essential to meet the growing demand for bone allografts.
Key Market Trends
Technological Advancements
Technological advancements have always been a catalyst for innovation and growth in various industries, and the healthcare sector is no exception. In recent years, the global bone allografts market has witnessed a remarkable surge in demand, thanks to the continuous evolution of cutting-edge technologies. Bone allografts, which involve the transplantation of bone tissue from a donor to a recipient, have become a crucial component in various orthopedic and dental procedures. Also, the partnership between two companies leads to the growth of global bone allografts market. For instance, in August 2022, Orthofix Medical Inc., a medical device company, collaborated with CGBio, a developer of synthetic bone grafts, to commercialize and advance the clinical development of Novosis recombinant human bone morphogenetic protein-2 (rhBMP-2) in the U.S. and Canadian markets.
In this report, the Global Bone Allografts Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Bone Allografts Market.
Global Bone Allografts market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: